Skip to content

Clinical trials

Terminated Lung Diseases trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Status: Terminated Country / region: France Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20111
20121
20142
20173
20181
20192
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aeris Therapeutics2
Assistance Publique - Hôpitaux de Paris1
AstraZeneca1
Blueprint Medicines Corporation1
Centre Hospitalier Universitaire Dijon1
Centre Hospitalier Universitaire de Saint Etienne1
Danone Global Research & Innovation Center1
Fondation Ophtalmologique Adolphe de Rothschild1
Groupe Hospitalier du Havre1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases15
Respiratory Tract Diseases6
Pulmonary Disease, Chronic Obstructive4
Carcinoma, Bronchogenic3
Carcinoma, Non-Small-Cell Lung3
Lung Neoplasms3
Neoplasms by Site3
Respiratory Tract Neoplasms3
Thoracic Neoplasms3
Adenocarcinoma2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.